Home Contacts The group on the web site map Credits Search for Welcome to Boehringer Ingelheim Italy Tuesday 29th September 2015 News Center Company profile Research and development Industrial production Products Code of Conduct Working with us Our Business Prescription drugs Hospital drugs Self-medication and well-being Veterinary drugs Active principles Therapeutic areas Analgesic / anti-inflammatory Cardio-cerebrovascular Gastroenterological Infectious disease Metabolic Neurological Oncological Pneumological Urological Archive Working with us The selection Young people Submit your resume NewsHome Discover the site reserved for journalists In the foreground 28/09/2015 Prolonged survival is less important than quality of life and disease control for most doctors, who treat patients with advanced lung cancer after first-line chemotherapy 28/09/2015 Advanced lung adenocarcinoma: Boehringer Ingelheim combination significantly reduced tumor progression compared to monotherapy 27/09/2015 ECC 2015: Boehringer Ingelheim Oral Target Therapy Demonstrates Superior Overall Survival, Compared to Control, in Patients with Advanced Squamous Cell Lung Cancer, Regardless of EGFR Mutational Status Archive Biopharmaceutical area Go to the site Resources and services FAQ Contacts site map Atrial fibrillation and stroke European Competition Social & Business Co-Creation Who we are The group in Italy The commercial divisions The group in figures History Awareness campaign Read Registered users E-mail Password Come in Sign in Why register Lost password? Boehringer Ingelheim around the world All branches Patient associations Read Scholarships Read The Boehringer Ingelheim Italia sites List of sites The health of the whole family © 2015 | All rights reserved - Last update: 14/07/2014 BOEHRINGER INGELHEIM ITALIA SpA - Company with sole shareholder and registered office in Milan, Via Lorenzini n ° 8. Share capital Euro 24,260,040.00 int. paid, Tax Code and Milan Company Register number 00421210485, VAT number 00421210485, REA Milan n ° 1370160 - PEC: bitspa@legalmail.it - Company subject to the management and coordination of CH Boehringer Sohn Company with sole shareholder Report Print Terms of use Accessibility Information on cookies